794 related articles for article (PubMed ID: 12113215)
1. Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
Assanasen P; Naclerio RM
Clin Allergy Immunol; 2002; 17():101-39. PubMed ID: 12113215
[TBL] [Abstract][Full Text] [Related]
2. Effect of antihistamines on epithelial cells.
Devalia JL; Davies RJ
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():64-8; discussion 69-71. PubMed ID: 10444215
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic properties of antihistamines.
Negro-Alvarez JM; Funes E; García Cánovas A; Hernández J; García-Sellés FJ; Pagán JA; López-Sánchez JD
Allergol Immunopathol (Madr); 1996; 24(4):177-83. PubMed ID: 8939275
[TBL] [Abstract][Full Text] [Related]
4. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
5. Effects of H1 antihistamines on adhesion molecules: a possible rationale for long-term treatment.
Ciprandi G; Passalacqua G; Canonica GW
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():49-53. PubMed ID: 10444212
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma.
Bachert C; Maspero J
J Asthma; 2011 Nov; 48(9):965-73. PubMed ID: 21970671
[TBL] [Abstract][Full Text] [Related]
7. Role of antihistamines in allergic disease.
Busse WW
Ann Allergy; 1994 Apr; 72(4):371-5. PubMed ID: 7908779
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
[TBL] [Abstract][Full Text] [Related]
9. Experimental models for the evaluation of treatment of allergic rhinitis.
Day JH; Ellis AK; Rafeiro E; Ratz JD; Briscoe MP
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):263-77; quiz 277-8, 315. PubMed ID: 16498847
[TBL] [Abstract][Full Text] [Related]
10. Antihistamines and epithelial cells.
Graziano FM; Cook EB; Stahl JL
Allergy Asthma Proc; 2000; 21(3):129-33. PubMed ID: 10892513
[TBL] [Abstract][Full Text] [Related]
11. Antiallergic effects of H1-receptor antagonists.
Baroody FM; Naclerio RM
Allergy; 2000; 55 Suppl 64():17-27. PubMed ID: 11291777
[TBL] [Abstract][Full Text] [Related]
12. Antihistamines in rhinoconjunctivitis.
Howarth P
Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
[TBL] [Abstract][Full Text] [Related]
13. Advances in the pharmacotherapy of allergic rhinitis: second-generation H1-receptor antagonists.
Corey JP
Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 2):584-92. PubMed ID: 8105440
[TBL] [Abstract][Full Text] [Related]
14. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis.
Abdelaziz MM; Devalia JL; Khair OA; Bayram H; Prior AJ; Davies RJ
J Allergy Clin Immunol; 1998 Mar; 101(3):410-20. PubMed ID: 9525460
[TBL] [Abstract][Full Text] [Related]
15. Intravital microscopic studies on acute mast cell-dependent inflammation.
Raud J
Acta Physiol Scand Suppl; 1989; 578():1-58. PubMed ID: 2471389
[TBL] [Abstract][Full Text] [Related]
16. H1-antihistamines in asthma.
Lordan JL; Holgate ST
Clin Allergy Immunol; 2002; 17():221-48. PubMed ID: 12113218
[TBL] [Abstract][Full Text] [Related]
17. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
Bernstein JA
Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
[TBL] [Abstract][Full Text] [Related]
18. Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses.
Lever R; Hefni A; Moffatt JD; Paul W; Page CP
Clin Exp Allergy; 2007 Jun; 37(6):909-17. PubMed ID: 17517105
[TBL] [Abstract][Full Text] [Related]
19. [The antiallergic and anti-inflammatory effects of the second generation of antihistamines].
Grzelewska-Rzymowska I; Kryczka M
Pol Merkur Lekarski; 1998 May; 4(23):277-80. PubMed ID: 9825663
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
